News

Novartis posts better-than-expected sales driven by medicine demand
The Swiss pharma company also raised its full-year guidance, with sales expected to grow by high-single digits and core ...
Novartis Pharma AG: Novartis continues strong momentum with double-digit sales growth, robust margin expansion and multiple approvals in Q1
Ad hoc announcement pursuant to Art. 53 LR Net sales grew +15% (cc1, +12% USD) with core operating income1 up +27% (cc, +23% USD) Sales growth driven by continued strong performance from Entresto ...
Novartis posts better-than-expected first-quarter sales, raises full-year guidance
Swiss pharmaceutical firm Novartis on Tuesday reported better-than-expected first-quarter sales and raised its full-year ...
The Manila Times5h
Novartis continues strong momentum with double-digit sales growth, robust margin expansion and multiple approvals in Q1
FDA granted an accelerated approval for Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Vanrafia can be ...
Shares Are Expensive With the Market Likely Extrapolating Telix's Current Sales Growth Rates
The solid cash conversion allows Telix to internally fund organic growth and flexibility to pursue acquisitions. We expect the company to reinvest the majority of earnings into R&D. We forecast ...